Effectiveness of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction After Radical Prostatectomy: A Systematic Review
Abstract
Erectile dysfunction (ED) is one of the most frequent complications following radical prostatectomy, with substantial implications for quality of life, psychological well-being, and interpersonal relationships. The pathophysiology involves a combination of cavernous nerve injury, vascular insufficiency, and structural alterations such as corporal fibrosis. Phosphodiesterase type 5 inhibitors (PDE5i) are recommended as first-line therapy; however, their effectiveness in post-prostatectomy ED remains variable and influenced by multiple clinical factors. The objective to systematically evaluate the effectiveness of PDE5 inhibitors in improving erectile function in patients with ED following radical prostatectomy. This systematic review was conducted in accordance with PRISMA guidelines. Literature searches were performed in PubMed, Scopus, and Google Scholar for studies published between 2017 and 2025. Randomized controlled trials and observational studies evaluating PDE5 inhibitors (sildenafil, tadalafil, vardenafil) in post-prostatectomy ED were included. Primary outcomes were erectile function scores (International Index of Erectile Function/IIEF) and recovery rates. The results twenty studies met inclusion criteria. PDE5 inhibitors demonstrated consistent improvement in erectile function scores across most studies (1–3). However, treatment outcomes varied significantly depending on nerve-sparing status, baseline erectile function, patient comorbidities, and timing of…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- 2024 update in heart failure
- An Eco-Friendly Solid-State Electrode Modified With ZnO Nanoparticles Decorated With MWCNT as an Electrochemical Sensor for the Determination of Avanafil in Pure Form, Dosage Form and Human Plasma
- Vascular involvement in idiopathic pulmonary fibrosis
- A novel technique- subendometrial autologous platelet rich plasma injection in patients with unresponsive thin endometrium undergoing frozen-thawed embryo transfer: a prospective cohort study
- Does metformin prolong pregnancy in preterm pre-eclampsia? A study protocol for a South African, hospital-based double-blind, randomised, placebo-controlled trial
- Combined Pulmonary Fibrosis and Emphysema (CPFE): A "New" Smoking-Related Interstitial Lung Disease (ILD)
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.